Clinical Trials Logo

CMV Disease clinical trials

View clinical trials related to CMV Disease.

Filter by:
  • No longer available  
  • Page 1

NCT ID: NCT03010332 No longer available - CMV Viremia Clinical Trials

Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Disease

Start date: n/a
Phase:
Study type: Expanded Access

This is an expanded access protocol designed to provide access of ATA230 to subjects with cytomegalovirus (CMV) viremia or disease, who are intolerant to, or failed, standard antiviral therapy and have no comparable treatment options.